States are pushing ahead with drug payment caps despite a federal court ruling that cast doubt on their enforceability.
U.S. District Court Chief Judge Daniel Domenico’s July 1 order temporarily blocked Colorado’s first-in-the nation cap on how much state-regulated health plans can pay for Enbrel, a high-priced prescription drug that treats chronic inflammatory and autoimmune conditions.
Already a subscriber? Sign in